Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system
The dopamine (DA) transporter (DAT) is a plasma membrane glycoprotein expressed in dopaminergic (DA-) cells that takes back DA into presynaptic neurons after its release. DAT dysfunction has been involved in different neuro-psychiatric disorders including Parkinson's disease (PD). On the other...
Main Authors: | Pedro Barroso-Chinea, Ignacio Cruz-Muros, Domingo Afonso-Oramas, Javier Castro-Hernández, Josmar Salas-Hernández, Abdelwahed Chtarto, Diego Luis-Ravelo, Marie Humbert-Claude, Liliane Tenenbaum, Tomás González-Hernández |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-04-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996116300043 |
Similar Items
-
Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease
by: Anna-Maija Penttinen, et al.
Published: (2018-06-01) -
Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands
by: Deniz Kirik, et al.
Published: (2017-01-01) -
Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
by: Tomás González-Hernández, et al.
Published: (2010-10-01) -
A possible role of GDNF expression by which cabergoline use affects corpus callosum
by: Georgios Mitsiakos, et al.
Published: (2018-12-01) -
Enhancement of tyrosine hydroxylase expression by Cordyceps militaris
by: Sapkota Kumar, et al.
Published: (2010-04-01)